DUBLIN, Ireland–(BUSINESS WIRE)–Elan Corporation, plc (NYSE: ELN) today announced that it will present at the Lazard Capital Markets 6th Annual Healthcare Conference, on Tuesday, November 17, 2009 at; 9:55 a.m. Eastern Time and 2:55 [...]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that holders of its 4.75% Convertible Senior Subordinated Notes due 2013 have agreed to exchange approximately $109.0 million in aggregate principal [...]

Study Will Use Nanoparticles to Track Stem Cells in Heart Tissue Regeneration

Physician Experience with Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome Also to be Presented

BERKELEY, Calif.–(BUSINESS WIRE)–Aduro BioTech, a privately held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, today announced completion of its Series [...]

NEW DELHI–(BUSINESS WIRE)–Duke University and Jubilant Organosys Limited, the largest integrated Custom Research and Manufacturing Services (CRAMS) and leading Drug Discovery and Development Services (DDDS) company in India, through its subsidiary, Jubilant Biosys Limited, [...]

SAN FRANCISCO–(BUSINESS WIRE)–Five Prime Therapeutics, Inc., a clinical stage biologics company focused on discovery and development of innovative protein and antibody therapeutics, announced today that Julia P. Gregory, FivePrime’s president and chief executive officer, [...]